Meet the Westchester Firm that Saved the President’s Life

This story received Honorable Mention in the Best COVID-19 Feature Story category from the 2022 New York State Press Association’s Better Newspaper Contest.

Last January, a blip on the viral radar went unnoticed by much of the world. By the time the public became aware of an emerging pestilence—soon to be known as COVID-19—infectious disease researchers at Tarrytown-based Regeneron Pharmaceuticals, Inc., were already on the hunt for new drugs that could combat the disease.

Click HERE to read the full story in the Examiner+.